| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.33B | +68.7% |
| Cost of Revenue | $1.36B | +63.9% |
| Gross Profit | $974.6M | +75.8% |
| R&D Expense | $168.8M | +60.0% |
| SG&A Expense | $140.0M | +34.5% |
| Operating Income | $448.3M | +107.7% |
| Interest Expense | $9.4M | -79.1% |
| Pre-tax Income | $452.0M | +273.8% |
| Income Tax | $54.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $473.2M | +296.6% |
| Short-term Investments | $1.14B | +27.0% |
| Accounts Receivable | $440.9M | +32.2% |
| Inventory | $149.7M | +101.2% |
| Current Assets | $2.26B | +54.8% |
| Total Assets | $3.08B | +48.3% |
| Current Liabilities | $638.2M | +45.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $744.8M | +111.6% |
| Capital Expenditures | $46.4M | -11.1% |
| Investing Cash Flow | -$371.9M | +69.5% |
| Financing Cash Flow | -$17.1M | -105.5% |
| Free Cash Flow | $698.4M | +133.0% |
| +323.0% |
| Net Income | $397.4M | +173.2% |
| Long-term Debt |
| $1.29B |
| +24.4% |
| Total Liabilities | $2.26B | +37.0% |
| Stockholders' Equity | $825.6M | +91.9% |